PATCH PREPARATION
    1.
    发明申请
    PATCH PREPARATION 审中-公开
    配对准备

    公开(公告)号:US20140023695A1

    公开(公告)日:2014-01-23

    申请号:US13983166

    申请日:2012-02-01

    IPC分类号: A61K31/496 A61K9/70

    CPC分类号: A61K31/496 A61K9/7061

    摘要: A patch preparation containing a support and an adhesive layer formed on one surface of the support, wherein the adhesive layer contains 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine or a physiologically acceptable acid addition salt thereof, an acrylic polymer, lactic acid, sesame oil and one or more kinds of stabilizers selected from 2-mercaptobenzimidazole, 2,6-di-tert-butyl-4-methylphenol and propyl gallate.A patch preparation containing a support and an adhesive layer containing lactic acid and magnesium aluminometasilicate and formed on at least one surface of the support, which preparation is superior in both skin permeability and adhesiveness in the presence of water.

    摘要翻译: 一种贴剂,其包含支撑体和形成在支持体的一个表面上的粘合剂层,其中粘合剂层含有2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8 ,9,10-六氢环辛[b]吡啶或其生理上可接受的酸加成盐,丙烯酸聚合物,乳酸,芝麻油和一种或多种选自2-巯基苯并咪唑,2,6-二叔丁基 -4-甲基苯酚和没食子酸丙酯。 一种贴剂,其含有载体和含有乳酸和硅酸铝镁的粘合剂层,并形成在载体的至少一个表面上,该制剂在水的存在下具有优异的皮肤渗透性和粘合性。

    PATCH PREPARATION
    2.
    发明申请
    PATCH PREPARATION 有权
    配对准备

    公开(公告)号:US20130315976A1

    公开(公告)日:2013-11-28

    申请号:US13983134

    申请日:2012-02-01

    IPC分类号: A61K9/70

    摘要: The problem of the present invention is to provide a patch preparation containing a drug (excluding 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine and a physiologically acceptable acid addition salt thereof), which is superior in both the skin permeability of a drug, and adhesiveness in the presence of water.A patch preparation containing a support and an adhesive layer on one surface of the support, wherein the adhesive layer contains a drug excluding 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine and a physiologically acceptable acid addition salt thereof, an acrylic polymer, lactic acid and magnesium aluminometasilicate.

    摘要翻译: 本发明的问题在于提供含有药物(不含2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢环辛酸 [b]吡啶及其生理上可接受的酸加成盐),其在药物的皮肤渗透性方面都优异,并且在水存在下的粘合性。 在载体的一个表面上含有载体和粘合剂层的贴片制剂,其中所述粘合剂层含有除2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7 ,8,9,10-六氢环辛基[b]吡啶及其生理上可接受的酸加成盐,丙烯酸聚合物,乳酸和硅酸铝镁。

    PRODUCTION METHOD FOR ADHESIVE PATCH
    3.
    发明申请
    PRODUCTION METHOD FOR ADHESIVE PATCH 审中-公开
    胶粘剂生产方法

    公开(公告)号:US20130302514A1

    公开(公告)日:2013-11-14

    申请号:US13983131

    申请日:2012-02-01

    IPC分类号: A61K9/70

    摘要: The problem of the present invention is to minimize the influence of lactic acid on the property of an adhesive layer, and provide a production method of a patch preparation, which is capable of affording a patch preparation superior in the property of an adhesive layer.A method of producing a patch preparation comprising (a): a step of forming an adhesive layer containing a drug (excluding 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine and a physiologically acceptable acid addition salt thereof), an acrylic polymer and an organic liquid component compatible with the acrylic polymer, but without containing lactic acid, and (b): a step of adding lactic acid to the aforementioned adhesive layer.

    摘要翻译: 本发明的问题是使乳酸对粘合剂层的性能的影响最小化,并且提供能够提供粘合剂层性能优异的贴剂的贴剂的制备方法。 一种制备贴剂的方法,包括(a):形成含有药物的粘合剂层(不包括2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7, 8,9,10-六氢环辛[b]吡啶及其生理上可接受的酸加成盐),丙烯酸类聚合物和与丙烯酸类聚合物相容但不含乳酸的有机液体成分,(b):添加 乳酸到上述粘合剂层。

    Patch preparation
    4.
    发明授权
    Patch preparation 有权
    补丁准备

    公开(公告)号:US09138419B2

    公开(公告)日:2015-09-22

    申请号:US13983134

    申请日:2012-02-01

    摘要: The problem of the present invention is to provide a patch preparation containing a drug (excluding 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine and a physiologically acceptable acid addition salt thereof), which is superior in both the skin permeability of a drug, and adhesiveness in the presence of water.A patch preparation containing a support and an adhesive layer on one surface of the support, wherein the adhesive layer contains a drug excluding 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine and a physiologically acceptable acid addition salt thereof, an acrylic polymer, lactic acid and magnesium aluminometasilicate.

    摘要翻译: 本发明的问题在于提供含有药物(不含2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢环辛酸 [b]吡啶及其生理上可接受的酸加成盐),其在药物的皮肤渗透性方面都优异,并且在水存在下的粘合性。 在载体的一个表面上含有载体和粘合剂层的贴片制剂,其中所述粘合剂层含有除2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7 ,8,9,10-六氢环辛基[b]吡啶及其生理上可接受的酸加成盐,丙烯酸聚合物,乳酸和硅酸铝镁。